4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sutro Biopharma, Inc. (STRO) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 133 employees. Its market capitalization is roughly $497 million. In the fiscal year ended 2025-12-31, STRO reported $102M in revenue and ($191M) in net income.
Sutro Biopharma, Inc. operates as an oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+.
Interactive charts & full statements → Open the STRO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $102M | $62M | $154M | $68M | — |
| Operating Income (EBIT) | ($105M) | ($238M) | ($89M) | ($129M) | — |
| Net Income | ($191M) | ($228M) | ($107M) | ($119M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $14M | $12M | $10M | $64M | $17M |
| Operating Income (EBIT) | ($30M) | ($34M) | ($39M) | $15M | ($48M) |
| Net Income | ($38M) | ($47M) | ($57M) | ($12M) | ($76M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $174M | $387M | $471M | $407M | — |
| Total Liabilities | $306M | $343M | $321M | $190M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive STRO viewer.
About TickerBase · Data methodology & sources